Seattle Genetics Reports First Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. RTX
6. COF
7. SMCI
8. TSLA
9. BRZE
10. GOOGL

Go back to Seattle Genetics Reports First Quarter 2019 Financial Results

Seattle Genetics (SGEN) Tops Q1 EPS by 21c, Revenues Beat; Offers FY19 Revenue Mid-Point Below Consensus

April 25, 2019 4:31 PM EDT

Seattle Genetics (NASDAQ: SGEN) reported Q1 EPS of ($0.08), $0.21 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $195.2 million versus the consensus estimate of $186.77 million.

ADCETRIS® (Brentuximab Vedotin) Net Sales in U.S. and Canada Were $135.0 Million in the First Quarter, an Increase of 42 Percent Over the First Quarter of... More